Real-time trafficking and signaling of the glucagon-like peptide-1 receptor.
Mol Cell Endocrinol · 2014
Last updated 2026-05-28The GLP-1 receptor, a key target for type 2 diabetes drugs, moves quickly inside cells when activated by natural GLP-1 or similar drugs like exendin-4 and liraglutide. Unlike the natural hormone, the drugs cause the receptor to recycle back to the cell surface more slowly, which may be linked to a longer-lasting signal inside the cell.
AI summary of the abstract below.
| Journal | Mol Cell Endocrinol, 2014 |
|---|---|
| Citations | 120 |
| Relative citation ratio | 3.77 |
| NIH percentile | 88 |
| Molecules | — |
Abstract
The glucagon-like peptide-1 incretin receptor (GLP-1R) of family B G protein-coupled receptors (GPCRs) is a major drug target in type-2-diabetes due to its regulatory effect on post-prandial blood-glucose levels. The mechanism(s) controlling GLP-1R mediated signaling are far from fully understood. A fundamental mechanism controlling the signaling capacity of GPCRs is the post-endocytic trafficking of receptors between recycling and degradative fates. Here, we combined microscopy with novel real-time assays to monitor both receptor trafficking and signaling in living cells. We find that the human GLP-1R internalizes rapidly and with similar kinetics in response to equipotent concentrations of GLP-1 and the stable GLP-1 analogues exendin-4 and liraglutide. Receptor internalization was confirmed in mouse pancreatic islets. GLP-1R is shown to be a recycling receptor with faster recycling rates mediated by GLP-1 as compared to exendin-4 and liraglutide. Furthermore, a prolonged cycling of ligand-activated GLP-1Rs was observed and is suggested to be correlated with a prolonged cAMP signal.
Verbatim abstract via PubMed 24275181 ↗